top of page

What is BEMER?

Dr. Klioze’s Testimonial

I first encountered the BEMER device after meeting Tony and Audrey Lewis at the Mayor’s Challenge in Ormond Beach, FL.  I was interested once I learned that BEMER technology increases vascular flow and recovery after exercise.  I used the device for two weeks, and had 17 different people, friends and family try it as well during this time. Most all of them noted improvement from reduced swelling, edema, pain from plantar fasciitis, muscle pain and improved range of motion.  I had a half marathon approaching and, with no change in my training, I experienced an 8-minute improvement in my time and my recovery was much faster, with no muscle cramps or fatigue after the race. I have learned since, that many athletes also use the device to recover more easily. I continue to use it for small injuries that occur while running, working in yard, or working out in the gym and it has also made a great impact on my sleep. BEMER improves circulation so your body can heal itself, but there are studies and references that it may also help reduce free radicals just like the electromagnetic impulse of the earth. I have enjoyed my device and feel that it has impacted my life. Our company rents and sells this device as we feel it enhances one’s overall health. Our team will be happy to meet with you and let you experience our BEMER device.

Selected Research Articles

In this 2022 randomized study conducted in Italy, 21 females of median 59 years of age affected by fibromyalgia received pulsed electromagnetic field - triple energy pain treatment (PEMF-TEPT) or a placebo at 2, 4 or 8 weeks. In addition, they were given a fibromyalgia impact questionnaire, a widespread pain index, a visual analog score, a symptoms severity scale and a short health survey questionnaire to fill out during the treatment period. Results: patients in the PEMF-TEPT therapy group experienced a significantly higher reduction in widespread pain compared to the placebo group and also reported a higher improvement in their fibromyalgia impact questionnaire, though not reaching statistical significance. Conclusion: In this pilot-controlled study PEMF-TEPT appeared to be safe and improved fibromyalgia symptoms.

Giovale, M., Novelli, L., Persico, L., Motta, F., Rampoldi, S., Galli, R., Monteforte, P., Doveri, M., Bianchi, G., Selmi, C. & Bottaro, L. (2022). Low-energy pulsed electromagnetic field therapy reduces pain in fibromyalgia: A randomized single-blind controlled pilot study. Rheumatology and Immunology Research, 3(2), 77-83.


A study conducted in China on rats and published on January 4, 2019 in Molecular Medicine Reports revealed that the administration of Low Frequency Pulsed Electro Magnetic Fields (LPEMFs) significantly promoted functional recovery following spinal cord-injury in rats by potentially modulating inflammation, oxidative stress and heat shock protein 70 (HSP70) levels.

Wang, C., Liu, Y., Wang, Y., Wei, Z., Suo, D., Ning, G., Wu, Q., Feng, S., & Wan, C. (2019). Low‑frequency pulsed electromagnetic field promotes functional recovery, reduces inflammation and oxidative stress, and enhances HSP70 expression following spinal cord injury. Molecular medicine reports, 19(3), 1687–1693.


Another NIH study was conducted again in Germany of 658 patients using the BEMER PEMF device from 4/2011 to 3/2013. Each patient was given a questionnaire from three scientifically recognized scales assessing sleep, pain and quality of life and asked to monitor their reaction over a period of 6 weeks. The results of the study clearly demonstrated that patients showed significant improvement in all the monitored categories.

Journal of Complementary and Integrative Medicine, Volume 10, Issue Supplement-English, Pages S5–S12, EISSN 1553-3840, ISSN 2194-6329, DOI: 


A PEMF double blinded study conducted in Germany (Impulse magnetic-field therapy for insomnia: A double-blind, placebo-controlled study) in 2001 of 101 patients over the period of 4 weeks assessed if PEMF can positively impact sleep disturbances. The treatment group had 50 participants and the sham group had 51. The final assessment was on the intensity of sleep latency, frequency of interruptions, sleepiness after rising, daytime sleepiness, difficulty with concentration, and daytime headaches. At conclusion of the study, 70% of the patients treated with PEMF had substantial or complete relief of their symptoms and 24% noticed a definite improvement. In the end, all areas showed a statistically significant improvement with P value <.0001.

Pelka, R.B., Jaenicke, C. & Gruenwald, J. Impulse magnetic-field therapy for insomnia: A double-blind, placebo-controlled study. Adv Therapy 18, 174–180 (2001):

bottom of page